{"id":412011,"date":"2021-01-11T08:34:00","date_gmt":"2021-01-11T13:34:00","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=412011"},"modified":"2021-01-11T08:34:00","modified_gmt":"2021-01-11T13:34:00","slug":"denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors\/","title":{"rendered":"Denali Therapeutics Announces Appointment of Nancy Thornberry to Board of Directors"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SOUTH SAN FRANCISCO, Calif., Jan.  11, 2021  (GLOBE NEWSWIRE) &#8212; Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases, today announced that Nancy Thornberry has joined the Board of Directors, effective January 8, 2021. Ms. Thornberry\u2019s extensive biotech leadership and pharmaceutical experience includes more than 30 years of development and discovery work in multiple disease areas, including diabetes and endocrinology.<\/p>\n<p>\u201cI\u2019m excited to welcome Nancy to the Board,\u201d said Ryan Watts, Ph.D., Denali\u2019s Chief Executive Officer. \u201cNancy\u2019s industry experience spans all stages of pharmaceutical development from the discovery of new molecular entities to clinical research leading to the approval of important new classes of medicines. Her perspective will be an asset as we continue to advance a broad portfolio of therapeutic candidates to treat neurodegeneration.\u201d<\/p>\n<p>\u201cIt\u2019s an honor to join Denali\u2019s Board of Directors,\u201d said Ms. Thornberry. \u201cWith a singular focus on neurodegeneration, Denali is tackling one of the biggest medical challenges that our society faces today. I am impressed with the breadth of Denali\u2019s pipeline and the vast opportunities afforded by its platform technology for delivering biotherapeutics to the brain. I look forward to applying my insights as a drug developer towards Denali\u2019s continued growth and success.\u201d<\/p>\n<p>Ms. Thornberry is Chief Executive Officer of Kallyope. She was formerly Senior Vice President and Franchise Head, Diabetes and Endocrinology, Merck &amp; Co. Inc. In this role she led discovery and clinical research in diabetes, osteoporosis, fertility, and contraception. Prior to her role as Franchise Head, she initiated and was a leader of Merck\u2019s dipeptidyl peptidase 4 (DPP-4) project, which resulted in the discovery of JANUVIA\u00ae for the treatment of Type 2 diabetes. Among other notable scientific accomplishments is the identification of the first caspase, interleukin-1\u03b2 converting enzyme (ICE\/caspase-1). For her scientific contributions Ms. Thornberry has received numerous awards, including the Merck Presidential Fellowship, Merck Directors Award, Heroes of Chemistry Award by the American Chemical Society, and in 2011 received the Pharmaceuticals Research and Manufacturers of America (PhRMA) Discoverers Award, which honors research scientists whose work has been of special benefit to humankind.<\/p>\n<p>\n        <strong>About Denali Therapeutics<\/strong>\n      <\/p>\n<p>Denali Therapeutics is a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases. Denali pursues new treatments by rigorously assessing genetically validated targets, engineering delivery across the BBB and guiding development through biomarkers that demonstrate target and pathway engagement. Denali is based in South San Francisco. For additional information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SbCdSamr-PAk-KA5d-VSnvOwSAWV0miReIsKsv11A2S8OLotUVtaLyyuSGwOtQzPBtQdBJu-bUFekv4OIdyZnFmej19NPWdbPQEadEe-gY1rRxDJCVN0YzGssCJa_4NS\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.denalitherapeutics.com<\/a><\/p>\n<p>\n        <strong>Investor Relations Contact:<\/strong>\n      <\/p>\n<p>Laura Hansen, Ph.D.<br \/>Vice President, Investor Relations<br \/>(650) 452-2747<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mJOJ3I_k6SxX2s6aSAALhxDKh7pC2sG1eXpBCr1Y5Wl-u8g__Yn8M52gZ_UgmGo7WSkYJpivBgzf025HInxlDw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">hansen@dnli.com<\/a>\u00a0<\/p>\n<p>\n        <strong>Media Contacts:<\/strong>\n      <\/p>\n<p>Lizzie Hyland<br \/>(646) 495-2706<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CNA-EXUBwTOHeoqiDBmlZAk8x0_hLWUMHK5g2LGDFbrcfj_Y9SMdJOLobNiJ6H9pKHH5VbHSUeONsl5nt4Z3DA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">lhyland@gpg.com<\/a>\u00a0<\/p>\n<p>or<\/p>\n<p>Morgan Warners<br \/>(202) 295-0124<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0Mzl0fkcFE6dM02bfbYM37ho1C__poERbc0EPG7vQgM1MCp99Xkb0Cz5YGYGGnVuFI-pc8rNkNjEHRlDnkJo8g==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">mwarners@gpg.com<\/a>\u00a0<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMzQ0MCMzOTEyMzM1IzIwOTM0Njg=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/7541863b-addd-4388-bfa7-3b2c6fa557be\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) &#8212; Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases, today announced that Nancy Thornberry has joined the Board of Directors, effective January 8, 2021. Ms. Thornberry\u2019s extensive biotech leadership and pharmaceutical experience includes more than 30 years of development and discovery work in multiple disease areas, including diabetes and endocrinology. \u201cI\u2019m excited to welcome Nancy to the Board,\u201d said Ryan Watts, Ph.D., Denali\u2019s Chief Executive Officer. \u201cNancy\u2019s industry experience spans all stages of pharmaceutical development from the discovery of new molecular entities to clinical research leading to the approval of important new classes of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Denali Therapeutics Announces Appointment of Nancy Thornberry to Board of Directors&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-412011","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Denali Therapeutics Announces Appointment of Nancy Thornberry to Board of Directors - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Denali Therapeutics Announces Appointment of Nancy Thornberry to Board of Directors - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) &#8212; Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases, today announced that Nancy Thornberry has joined the Board of Directors, effective January 8, 2021. Ms. Thornberry\u2019s extensive biotech leadership and pharmaceutical experience includes more than 30 years of development and discovery work in multiple disease areas, including diabetes and endocrinology. \u201cI\u2019m excited to welcome Nancy to the Board,\u201d said Ryan Watts, Ph.D., Denali\u2019s Chief Executive Officer. \u201cNancy\u2019s industry experience spans all stages of pharmaceutical development from the discovery of new molecular entities to clinical research leading to the approval of important new classes of &hellip; Continue reading &quot;Denali Therapeutics Announces Appointment of Nancy Thornberry to Board of Directors&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-11T13:34:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMzQ0MCMzOTEyMzM1IzIwOTM0Njg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Denali Therapeutics Announces Appointment of Nancy Thornberry to Board of Directors\",\"datePublished\":\"2021-01-11T13:34:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors\\\/\"},\"wordCount\":468,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMzQ0MCMzOTEyMzM1IzIwOTM0Njg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors\\\/\",\"name\":\"Denali Therapeutics Announces Appointment of Nancy Thornberry to Board of Directors - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMzQ0MCMzOTEyMzM1IzIwOTM0Njg=\",\"datePublished\":\"2021-01-11T13:34:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMzQ0MCMzOTEyMzM1IzIwOTM0Njg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMzQ0MCMzOTEyMzM1IzIwOTM0Njg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Denali Therapeutics Announces Appointment of Nancy Thornberry to Board of Directors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Denali Therapeutics Announces Appointment of Nancy Thornberry to Board of Directors - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"Denali Therapeutics Announces Appointment of Nancy Thornberry to Board of Directors - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) &#8212; Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases, today announced that Nancy Thornberry has joined the Board of Directors, effective January 8, 2021. Ms. Thornberry\u2019s extensive biotech leadership and pharmaceutical experience includes more than 30 years of development and discovery work in multiple disease areas, including diabetes and endocrinology. \u201cI\u2019m excited to welcome Nancy to the Board,\u201d said Ryan Watts, Ph.D., Denali\u2019s Chief Executive Officer. \u201cNancy\u2019s industry experience spans all stages of pharmaceutical development from the discovery of new molecular entities to clinical research leading to the approval of important new classes of &hellip; Continue reading \"Denali Therapeutics Announces Appointment of Nancy Thornberry to Board of Directors\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-11T13:34:00+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMzQ0MCMzOTEyMzM1IzIwOTM0Njg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Denali Therapeutics Announces Appointment of Nancy Thornberry to Board of Directors","datePublished":"2021-01-11T13:34:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors\/"},"wordCount":468,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMzQ0MCMzOTEyMzM1IzIwOTM0Njg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors\/","name":"Denali Therapeutics Announces Appointment of Nancy Thornberry to Board of Directors - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMzQ0MCMzOTEyMzM1IzIwOTM0Njg=","datePublished":"2021-01-11T13:34:00+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMzQ0MCMzOTEyMzM1IzIwOTM0Njg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMzQ0MCMzOTEyMzM1IzIwOTM0Njg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/denali-therapeutics-announces-appointment-of-nancy-thornberry-to-board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Denali Therapeutics Announces Appointment of Nancy Thornberry to Board of Directors"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/412011","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=412011"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/412011\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=412011"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=412011"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=412011"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}